phrykt

Werewolf Therapeutics, Inc. (HOWL): who owns it and who trades it

As of Nov 16, 2026, HOWL insiders reported 105 open-market sales worth $3.9M and no purchases in the last 12 months, with 76% of the sale value made under pre-set 10b5-1 plans. The largest seller was Luke Evnin (Director), with $2.3M. 2 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Werewolf Therapeutics

From the latest filings

Overall: more selling than buying. Insiders mostly sold. Famous investors was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Insider trades

In the last 12 months, HOWL insiders reported $0 of open-market purchases and $3.9M of sales. 76% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$3.9M
105 trades, 7 people
Sales under a 10b5-1 plan
76%
Share of sale value
Latest trade
Jul 7, 2026
Filed Jul 8, 2026

Purchases and sales by month

$1.1M$1.1MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Jul 7, 2026Luke EvninDirectorSale plan107,429$0.31$33.3KForm 4
Jul 6, 2026Luke EvninDirectorSale plan35,770$0.32$11.4KForm 4
Jun 29, 2026Luke EvninDirectorSale plan157,084$0.30$47.1KForm 4
Jun 17, 2026Ra Capital Management, L.P. +310% ownerSale389,216$0.35$136KForm 4
Jun 17, 2026Ra Capital Management, L.P. +310% ownerSale27,695$0.35$9.7KForm 4
Jun 16, 2026Ra Capital Management, L.P. +310% ownerSale139,686$0.37$51.7KForm 4
Jun 16, 2026Ra Capital Management, L.P. +310% ownerSale9,939$0.37$3.7KForm 4
Jun 15, 2026Ra Capital Management, L.P. +310% ownerSale120,216$0.39$46.9KForm 4
Jun 15, 2026Ra Capital Management, L.P. +310% ownerSale8,554$0.39$3.3KForm 4
Jun 12, 2026Ra Capital Management, L.P. +310% ownerSale159,119$0.40$63.6KForm 4
Jun 12, 2026Ra Capital Management, L.P. +310% ownerSale11,322$0.40$4.5KForm 4
Jun 11, 2026Peter Kolchinsky +310% ownerSale17,437$0.38$6.6KForm 4
Jun 11, 2026Peter Kolchinsky +310% ownerSale245,066$0.38$93.1KForm 4
Jun 10, 2026Peter Kolchinsky +310% ownerSale42,872$0.37$15.9KForm 4
Jun 10, 2026Peter Kolchinsky +310% ownerSale3,051$0.37$1.1KForm 4
Jun 9, 2026Peter Kolchinsky +310% ownerSale345,235$0.37$128KForm 4
Jun 9, 2026Peter Kolchinsky +310% ownerSale24,565$0.37$9.1KForm 4
Jun 9, 2026Luke EvninDirectorSale plan76,928$0.37$28.5KForm 4
Jun 8, 2026Luke EvninDirectorSale plan60,547$0.40$24.2KForm 4
Jun 5, 2026Luke EvninDirectorSale plan24,946$0.40$10KForm 4
Jun 4, 2026Luke EvninDirectorSale plan20,072$0.44$8.8KForm 4
Jun 3, 2026Luke EvninDirectorSale plan29,749$0.42$12.5KForm 4
Jun 2, 2026Luke EvninDirectorSale plan29,595$0.45$13.3KForm 4
Jun 1, 2026Luke EvninDirectorSale plan80,459$0.47$37.8KForm 4
May 29, 2026Luke EvninDirectorSale plan32,556$0.45$14.7KForm 4
May 28, 2026Luke EvninDirectorSale plan27,698$0.46$12.7KForm 4
May 27, 2026Luke EvninDirectorSale plan80,852$0.48$38.8KForm 4
May 26, 2026Luke EvninDirectorSale plan67,950$0.47$31.9KForm 4
May 22, 2026Luke EvninDirectorSale plan87,425$0.45$39.3KForm 4
May 21, 2026Luke EvninDirectorSale plan36,387$0.42$15.3KForm 4
May 20, 2026Luke EvninDirectorSale plan85,895$0.43$36.9KForm 4
May 19, 2026Luke EvninDirectorSale plan62,970$0.45$28.3KForm 4
May 18, 2026Luke EvninDirectorSale plan22,184$0.50$11.1KForm 4
May 13, 2026Luke EvninDirectorSale plan44,679$0.54$24.1KForm 4
May 12, 2026Luke EvninDirectorSale plan67,885$0.64$43.4KForm 4
May 12, 2026Ra Capital Management, L.P. +310% ownerSale6,719$0.64$4.3KForm 4
May 12, 2026Ra Capital Management, L.P. +310% ownerSale94,432$0.64$60.4KForm 4
May 11, 2026Luke EvninDirectorSale plan33,948$0.67$22.7KForm 4
May 11, 2026Ra Capital Management, L.P. +310% ownerSale5,812$0.67$3.9KForm 4
May 11, 2026Ra Capital Management, L.P. +310% ownerSale81,678$0.67$54.7KForm 4
May 8, 2026Luke EvninDirectorSale plan305,741$0.70$214KForm 4
May 8, 2026Ra Capital Management, L.P. +310% ownerSale351,514$0.71$250KForm 4
May 8, 2026Ra Capital Management, L.P. +310% ownerSale25,012$0.71$17.8KForm 4
May 7, 2026Luke EvninDirectorSale plan79,086$0.63$49.8KForm 4
May 6, 2026Luke EvninDirectorSale plan14,635$0.66$9.7KForm 4
May 5, 2026Luke EvninDirectorSale plan6,860$0.69$4.7KForm 4
May 4, 2026Luke EvninDirectorSale plan47,963$0.72$34.5KForm 4
May 1, 2026Luke EvninDirectorSale plan58,394$0.73$42.6KForm 4
Apr 30, 2026Luke EvninDirectorSale plan168,262$0.72$121KForm 4
Apr 29, 2026Luke EvninDirectorSale plan56,559$0.69$39KForm 4
Apr 28, 2026Luke EvninDirectorSale plan95,412$0.73$69.7KForm 4
Apr 27, 2026Luke EvninDirectorSale plan53,940$0.85$45.8KForm 4
Jan 16, 2026Luke EvninDirectorSale plan38,782$0.54$20.9KForm 4
Jan 15, 2026Luke EvninDirectorSale plan37,413$0.55$20.6KForm 4
Jan 14, 2026Luke EvninDirectorSale plan30,616$0.57$17.5KForm 4
Jan 13, 2026Luke EvninDirectorSale plan43,198$0.55$23.8KForm 4
Jan 12, 2026Luke EvninDirectorSale plan58,980$0.57$33.6KForm 4
Jan 9, 2026Luke EvninDirectorSale plan24,678$0.61$15.1KForm 4
Jan 8, 2026Luke EvninDirectorSale plan7,716$0.63$4.9KForm 4
Jan 7, 2026Luke EvninDirectorSale plan11,915$0.64$7.6KForm 4
Jan 6, 2026Luke EvninDirectorSale plan40,761$0.65$26.5KForm 4
Jan 5, 2026Luke EvninDirectorSale plan18,378$0.64$11.8KForm 4
Jan 2, 2026Luke EvninDirectorSale plan18,568$0.63$11.7KForm 4
Dec 31, 2025Luke EvninDirectorSale plan24,962$0.62$15.5KForm 4
Dec 30, 2025Luke EvninDirectorSale plan34,847$0.61$21.3KForm 4
Dec 29, 2025Luke EvninDirectorSale plan108,606$0.61$66.2KForm 4
Dec 26, 2025Luke EvninDirectorSale plan35,632$0.63$22.4KForm 4
Dec 24, 2025Luke EvninDirectorSale plan16,310$0.65$10.6KForm 4
Dec 23, 2025Luke EvninDirectorSale plan71,428$0.63$45KForm 4
Dec 22, 2025Luke EvninDirectorSale plan59,307$0.69$40.9KForm 4
Dec 17, 2025Luke EvninDirectorSale plan9,983$1.14$11.4KForm 4
Dec 16, 2025Luke EvninDirectorSale plan14,548$1.05$15.3KForm 4
Dec 15, 2025Luke EvninDirectorSale plan23,640$1.07$25.3KForm 4
Dec 12, 2025Luke EvninDirectorSale plan17,858$1.08$19.3KForm 4
Dec 11, 2025Luke EvninDirectorSale plan28,009$1.07$30KForm 4
Dec 10, 2025Luke EvninDirectorSale plan37,104$1.06$39.3KForm 4
Dec 9, 2025Luke EvninDirectorSale plan44,570$1.01$45KForm 4
Dec 8, 2025Luke EvninDirectorSale plan34,041$0.99$33.7KForm 4
Dec 5, 2025Luke EvninDirectorSale plan16,568$0.97$16.1KForm 4
Dec 4, 2025Luke EvninDirectorSale plan53,416$0.97$51.8KForm 4
Dec 4, 2025MPM BioVentures 2014 (B), L.P. +4OtherSale plan83,230$0.97$80.7KForm 4
Dec 3, 2025Luke EvninDirectorSale plan36,726$0.87$32KForm 4
Dec 3, 2025MPM BioVentures 2014 (B), L.P. +4OtherSale plan57,225$0.87$49.8KForm 4
Dec 2, 2025Luke EvninDirectorSale plan38,043$0.89$33.9KForm 4
Dec 2, 2025MPM BioVentures 2014 (B), L.P. +4OtherSale plan59,277$0.89$52.8KForm 4
Dec 1, 2025Luke EvninDirectorSale plan39,096$0.94$36.8KForm 4
Dec 1, 2025MPM Asset Management Investors BV2014 LLC +410% ownerSale plan60,917$0.94$57.3KForm 4
Nov 28, 2025Luke EvninDirectorSale plan13,014$0.99$12.9KForm 4
Nov 28, 2025MPM Asset Management Investors BV2014 LLC +410% ownerSale plan20,277$0.99$20.1KForm 4
Nov 26, 2025Luke EvninDirectorSale plan38,978$0.98$38.2KForm 4
Nov 26, 2025MPM Asset Management Investors BV2014 LLC +410% ownerSale plan60,733$0.98$59.5KForm 4
Nov 25, 2025Luke EvninDirectorSale plan27,297$0.92$25.1KForm 4
Nov 25, 2025MPM BioVentures 2014 GP LLC +410% ownerSale plan42,533$0.92$39.1KForm 4
Nov 24, 2025Luke EvninDirectorSale plan56,992$0.98$55.9KForm 4
Nov 24, 2025MPM BioVentures 2014 GP LLC +410% ownerSale plan88,802$0.98$87KForm 4
Nov 21, 2025Luke EvninDirectorSale plan41,287$0.83$34.3KForm 4
Nov 21, 2025MPM BioVentures 2014 GP LLC +410% ownerSale plan64,331$0.83$53.4KForm 4
Nov 20, 2025Luke EvninDirectorSale plan26,411$0.89$23.5KForm 4
Nov 20, 2025MPM BioVentures 2014 LLC +410% ownerSale plan41,152$0.89$36.6KForm 4
Nov 19, 2025Luke EvninDirectorSale plan42,566$0.94$40KForm 4

Latest 100 of 105 trades in the last 12 months.

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Luke EvninDirector–$2.3MJul 7, 2026
Ra Capital Management, L.P.10% owner–$710KJun 17, 2026
Peter Kolchinsky10% owner–$254KJun 11, 2026
MPM BioVentures 2014 LLC10% owner–$202KNov 20, 2025
MPM BioVentures 2014 (B), L.P.Other–$183KDec 4, 2025
MPM BioVentures 2014 GP LLC10% owner–$180KNov 25, 2025
MPM Asset Management Investors BV2014 LLC10% owner–$137KDec 1, 2025
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

HOWL short interest

Low short interest. 4.4% of HOWL shares are sold short: about 1 share in 23. Over the last 12 reports the number of shares short went up 219%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 2.13M HOWL shares were sold short, 4.4% of the shares outstanding, down 9.7% from the report before. At the average daily volume of 333,048 shares, buying them all back would take about 6.4 trading days (days to cover).

Shares short, % of all shares

4.38%May 15Oct 305.74%

Days to cover

6.4May 15Oct 307.2

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20262.13M4.38%-10%333,0486.4
Oct 15, 20262.36M4.85%-6%462,2335.1
Sep 30, 20262.51M5.17%+47%679,2913.7
Sep 15, 20261.71M3.51%+2%897,2871.9
Aug 31, 20261.67M3.43%+56%35.56M1.0
Aug 14, 20261.07M2.20%-3%288,6053.7
Jul 31, 20261.10M2.26%+18%844,0691.3
Jul 15, 2026934,3401.92%+10%910,8201.0
Jun 30, 2026847,0961.74%-12%1.10M1.0
Jun 15, 2026964,6241.98%+2%495,7471.9
May 29, 2026949,5981.95%+42%609,2171.6
May 15, 2026667,6261.37%-8%678,4651.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Werewolf Therapeutics company events

Werewolf Therapeutics filed 10 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership, listing). The latest was on Nov 9, 2026.

  1. Nov 9, 2026AnnouncementShared information with investors. Filing
  2. Aug 21, 2026AgreementWerewolf Therapeutics, Inc., a Delaware corporation, entered into an Agreement and Plan of Merger by and among Ambros Therapeutics, Inc., a Delaware corporation, Werewolf, and Wave Atlantis Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Werewolf. Filing
  3. Aug 20, 2026AgreementWerewolf Therapeutics, Inc. entered into an asset purchase agreement with EMD Serono Research & Development Institute Inc., pursuant to which, and subject to the terms and conditions thereof, the Company sold to EMD technology comprising (i) its pre-clinical INDUCER platform, including all patents… Filing
  4. Jul 31, 2026ResultsReleased financial results. Filing
  5. May 7, 2026ResultsReleased financial results. Filing
  6. Mar 27, 2026ResultsReleased financial results. Filing
  7. Feb 24, 2026AnnouncementWerewolf Therapeutics, Inc. issued a press release announcing that it plans to explore strategic alternatives and has engaged Piper Sandler & Co. as its exclusive financial advisor to assist in the strategic evaluation. Filing
  8. Feb 13, 2026LeadershipDeparture of Certain Officers As part of the Reduction, on February 9, 2026, the Company and each of Timothy W. Trost, Chief Financial Officer of the Company, and Dr. Randi Isaacs, M.D., Chief Medical Officer of the Company, agreed that Mr. Trost and Dr. Isaacs would resign as Chief Financial… Filing
  9. Feb 6, 2026ListingWerewolf Therapeutics, Inc. received a deficiency letter from the Listing Qualifications Department of the Nasdaq Stock Market, LLC notifying the Company that, for the last 30 consecutive business days, the bid price for the Company’s common stock had closed below $1.00 per share, which is the… Filing
  10. Dec 18, 2025AnnouncementWerewolf Therapeutics, Inc. issued a press release announcing a pipeline update, including a review of recent data for its INDUKINE ™ programs, and a business overview of its priorities for 2026 that includes a focus on the Company’s highly differentiated INDUCER T-cell engager platform. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Werewolf Therapeutics financials

Famous investors that hold HOWL

2 of the 50 well-known investors we track reported holding HOWL in their latest 13F filing. The largest position is Ken Griffin's, worth $511K.

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 2026553,702$511K0.0%New
Jim Simons · Renaissance TechnologiesQ3 2026550,935$508K0.0%-18%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named HOWL in the last 120 days.

FiledHolderFormStake
Nov 16, 2026BALYASNY ASSET MANAGEMENT L.P.13G6.3%
Nov 16, 2026BALYASNY ASSET MANAGEMENT L.P.13G6.3%

Questions about Werewolf Therapeutics, Inc. (HOWL) stock

Are HOWL insiders buying or selling?

In the last 12 months, HOWL insiders reported no open-market purchases and 105 sales worth $3.9M. The latest trade was on Jul 7, 2026. See every trade.

What is the short interest in HOWL?

As of Oct 30, 2026, 2.13M HOWL shares were sold short, 4.4% of the shares outstanding, down 9.7% from the report before. At the average daily volume of 333,048 shares, buying them all back would take about 6.4 trading days (days to cover). See the history.

Which famous investors hold HOWL?

2 of the 50 well-known investors we track reported HOWL in their latest 13F filing, including Ken Griffin, Jim Simons. The largest position is worth $511K. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.